| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in IONS over the last quarter tilts toward selling: insiders offloaded a net 196,094 shares worth roughly $15.4M.
Classified under Biotechnology (Health Care sector), IONS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 156.0K | $8.76M | - | |
| CEO | 99.9K | $5.61M | - | |
| CFO | 82.7K | $4.64M | - | |
| VP | 74.4K | $4.18M | - | |
| VP | 69.7K | $3.91M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | Swayze Eric63 | EVP Research | Sale+OE | 7,176 | $32.84 | $235,678.22 | -13.5% | -12.2% | +136.5% | |
| Jan 16, 2025 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sale+OE | 6,523 | $32.79 | $213,889.17 | -10.0% | -12.2% | +136.5% | |
| Jan 16, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 7,360 | $32.83 | $241,628.80 | -10.7% | -12.2% | +136.5% | |
| Jan 16, 2025 | Monia Brett P60 | Chief Executive Officer | Sale+OE | 33,445 | $32.63 | $1,091,444.13 | -13.9% | -12.2% | +136.5% | |
| Jan 16, 2025 | Hougen Elizabeth L55 | EVP, Finance &CFO | Sale+OE | 8,870 | $32.81 | $290,989.22 | -7.6% | -12.2% | +136.5% | |
| Jan 16, 2025 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 7,072 | $32.86 | $232,407.14 | -6.8% | -12.2% | +136.5% | |
| Jan 16, 2025 | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sale+OE | 4,267 | $32.78 | $139,855.19 | -21.1% | -12.2% | +136.5% | |
| Jan 16, 2025 | Birchler Brian55 | EVP, Corp And Development Ops | Sale+OE | 5,400 | $32.70 | $176,580.00 | -8.9% | -12.2% | +136.5% | |
| Jan 16, 2025 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sale+OE | 6,752 | $32.90 | $222,113.79 | -6.9% | -12.2% | +136.5% | |
| Jan 16, 2025 | Baroldi Joseph53 | EVP, Chief Business Officer | Sale+OE | 4,430 | $32.70 | $144,861.00 | -13.6% | -12.2% | +136.5% |